Hepatitis Monthly

Published by: Kowsar

Drug-Resistance Associated Mutations in Polymerase (P) Gene of Hepatitis B Virus Isolated From Malaysian HBV Carriers

Jeyanthi Suppiah 1 , * , Rozainanee Mohd Zain 2 , Salbiah Haji Nawi 2 , Norazlah Bahari 3 and Zainah Saat 1
Authors Information
1 Virology Unit, Institute for Medical Research, Kuala Lumpur, Malaysia
2 Microbiology Unit, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia
3 Pathology Unit, Selayang Hospital, Selangor, Malaysia
Article information
  • Hepatitis Monthly: January 01, 2014, 14 (1); e13173
  • Published Online: January 5, 2014
  • Article Type: Research Article
  • Received: July 1, 2013
  • Revised: October 9, 2013
  • Accepted: November 1, 2013
  • DOI: 10.5812/hepatmon.13173

To Cite: Suppiah J, Mohd Zain R, Haji Nawi S, Bahari N, Saat Z. et al. Drug-Resistance Associated Mutations in Polymerase (P) Gene of Hepatitis B Virus Isolated From Malaysian HBV Carriers, Hepat Mon. 2014 ;14(1):e13173. doi: 10.5812/hepatmon.13173.

Abstract
Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. MMWR. 2005; 54(16): 1-32
  • 2. Bowyer SM, Sim JG. Relationships within and between genotypes of hepatitis B virus at points across the genome: footprints of recombination in certain isolates. J Gen Virol. 2000; 81: 379-92[PubMed]
  • 3. Allen MI, Deslauriers M, Andrews CW, Tipples GA, Walters KA, Tyrrell DL, et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group. Hepatology. 1998; 27(6): 1670-7[DOI][PubMed]
  • 4. Har Ton So, Meng Tan Tsui, Siang Khoo Boo, Zawawi Mazlam, Thanaletchimy Nagalingam. Hepatitis B Virus Genotypes and Pre-core/Core Promoter Mutations in Malaysian Carriers. Malays J Biochem Mol Biol. 2005; 12: 14-20
  • 5. Ong HT, Duraisamy G, Kee Peng N, Wen Siang T, Seow HF. Genotyping of hepatitis B virus in Malaysia based on the nucleotide sequence of preS and S genes. Microbes Infect. 2005; 7(3): 494-500[DOI][PubMed]
  • 6. Sugauchi F, Mizokami M, Orito E, Ohno T, Kato H, Suzuki S, et al. A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. J Gen Virol. 2001; 82: 883-92[PubMed]
  • 7. Brunjes PC. A comparative study of prenatal development in the olfactory bulb, neocortex and hippocampal region of the precocial mouse Acomys cahirinus and rat. Brain Res Dev Brain Res. 1989; 49(1): 7-25[PubMed]
  • 8. Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol. 2002; 83: 2059-73[PubMed]
  • 9. Tran TT, Trinh TN, Abe K. New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol. 2008; 82(11): 5657-63[DOI][PubMed]
  • 10. Tatematsu K, Tanaka Y, Kurbanov F, Sugauchi F, Mano S, Maeshiro T, et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol. 2009; 83(20): 10538-47[DOI][PubMed]
  • 11. Lim CK, Tan JT, Khoo JB, Ravichandran A, Low HM, Chan YC, et al. Correlations of HBV genotypes, mutations affecting HBeAg expression and HBeAg/ anti-HBe status in HBV carriers. Int J Med Sci. 2006; 3(1): 14-20[PubMed]
  • 12. Lindh M, Andersson AS, Gusdal A. Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method. J Infect Dis. 1997; 175(6): 1285-93[PubMed]
  • 13. Magnius LO, Norder H. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology. 1995; 38(1-2): 24-34[PubMed]
  • 14. Schaefer S. Hepatitis B virus: significance of genotypes. J Viral Hepat. 2005; 12(2): 111-24[DOI][PubMed]
  • 15. Meldal BH, Bon AH, Prati D, Ayob Y, Allain JP. Diversity of hepatitis B virus infecting Malaysian candidate blood donors is driven by viral and host factors. J Viral Hepat. 2011; 18(2): 91-101[DOI][PubMed]
  • 16. Betka J, Valvoda M, Hruby J, Skrivan J. [The surgical approach and results of implantation of the Czech cochlear neuroprosthesis]. Cas Lek Cesk. 1989; 128(11): 339-41[PubMed]
  • 17. Schildgen O, Sirma H, Funk A, Olotu C, Wend UC, Hartmann H, et al. Variant of hepatitis B virus with primary resistance to adefovir. N Engl J Med. 2006; 354(17): 1807-12[DOI][PubMed]
  • 18. Tenney DJ, Rose RE, Baldick CJ, Pokornowski KA, Eggers BJ, Fang J, et al. Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naive patients is rare through 5 years of therapy. Hepatology. 2009; 49(5): 1503-14[DOI][PubMed]
  • 19. Lai CL, Gane E, Liaw YF, Hsu CW, Thongsawat S, Wang Y, et al. Telbivudine versus lamivudine in patients with chronic hepatitis B. N Engl J Med. 2007; 357(25): 2576-88[DOI][PubMed]
  • 20. Fujisaki S, Yokomaku Y, Shiino T, Koibuchi T, Hattori J, Ibe S, et al. Outbreak of infections by hepatitis B virus genotype A and transmission of genetic drug resistance in patients coinfected with HIV-1 in Japan. J Clin Microbiol. 2011; 49(3): 1017-24[DOI][PubMed]
  • 21. Strasfeld L, Chou S. Antiviral drug resistance: mechanisms and clinical implications. Infect Dis Clin North Am. 2010; 24(2): 413-37[DOI][PubMed]
  • 22. Tacke F, Shirvani-Dastgerdi E. Impact of Drug-Resistance Polymerase Mutations on the Replication of HBeAg-Positive and HBeAg-Negative Hepatitis B Virus Strains in Vitro. Hepat Mon. 2012; 12(6): 357-60[DOI][PubMed]
  • 23. Fung S, Kwan P, Fabri MJ, Horban A, Petr Husa P, Hann HH, et al. Efficacy and safety of Tenofovir DF (TDF) in chronic hepatitis B virus infected patients with documented lamivudine resistance (LAM-R).: 2012;
  • 24. Marcellin P, Gane E, Buti M, Afdhal N, Sievert W, Jacobson IM, et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study. Lancet. 2013; 381(9865): 468-75[DOI][PubMed]
  • 25. Lee YS, Suh DJ, Lim YS, Jung SW, Kim KM, Lee HC, et al. Increased risk of adefovir resistance in patients with lamivudine-resistant chronic hepatitis B after 48 weeks of adefovir dipivoxil monotherapy. Hepatology. 2006; 43(6): 1385-91[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments